Glucocorticoid supplementation during ovulation induction for assisted reproductive technology: a systematic review and meta-analysis

References

• Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65–76. doi:10.1001/jama.2021.4788.
   PubMed Web of Science ®Google Scholar
• Kushnir VA, Barad DH, Albertini DF, et al. Systematic review of worldwide trends in assisted reproductive technology 2004–2013. Reprod Biol Endocrinol. 2017;15(1):6. doi:10.1186/s12958-016-0225-2.
   PubMedGoogle Scholar
• Chronopoulou E, Harper JC. IVF culture media: past, present and future. Hum Reprod Update. 2015;21(1):39–55. doi:10.1093/humupd/dmu040.
   PubMed Web of Science ®Google Scholar
• Benaglia L, Busnelli A, Biancardi R, et al. Oocyte retrieval difficulties in women with ovarian endometriomas. Reprod Biomed Online. 2018;37(1):77–84. doi:10.1016/j.rbmo.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Listijono D, Kilani S, Tilia L, et al. Is measurement of progesterone level prior to FSH stimulation useful in GnRH-antagonist cycles? Hum Fertil. 2015;18(4):234–237. doi:10.3109/14647273.2015.1038658.
   PubMed Web of Science ®Google Scholar
• Robertson SA, Jin M, Yu D, et al. Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise. Hum Reprod. 2016;31(10):2164–2173. doi:10.1093/humrep/dew186.
   PubMed Web of Science ®Google Scholar
• van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol. 2009;85(1):4–19. doi:10.1189/jlb.0708395.
   PubMed Web of Science ®Google Scholar
• Kaye L, Bartels C, Bartolucci A, et al. Old habits die hard: retrospective analysis of outcomes with use of corticosteroids and antibiotics before embryo transfer. Fertil Steril. 2017;107(6):1336–1340. doi:10.1016/j.fertnstert.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Turi A, Giannubilo SR, Zanconi S, et al. Preconception steroid treatment in infertile women with antithyroid autoimmunity undergoing ovarian stimulation and intrauterine insemination: a double-blind, randomized, prospective cohort study. Clin Ther. 2010;32(14):2415–2421. doi:10.1016/j.clinthera.2011.01.010.
   PubMed Web of Science ®Google Scholar
• Fan J, Zhong Y, Chen C. Combined treatment of prednisone and aspirin, starting before ovulation induction, may improve reproductive outcomes in ANA-positive patients. Am J Reprod Immunol. 2016;76(5):391–395. doi:10.1111/aji.12559.
   PubMed Web of Science ®Google Scholar
• Revelli A, Dolfin E, Gennarelli G, et al. Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study. Fertil Steril. 2008;90(5):1685–1691. doi:10.1016/j.fertnstert.2007.08.037.
   PubMed Web of Science ®Google Scholar
• Keay SD, Liversedge NH, Mathur RS, et al. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol. 1997;104(5):521–527. doi:10.1111/j.1471-0528.1997.tb11525.x.
   PubMedGoogle Scholar
• Trott EA, Plouffe L, Jr., Hansen K, et al. Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: beneficial effects of the addition of dexamethasone during the follicular phase. Fertil Steril. 1996;66(3):484–486. doi:10.1016/s0015-0282(16)58525-2.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Rabenbauer B, Wildt L. The effect of flutamide on pulsatile gonadotrophin secretion in hyperandrogenaemic women. Hum Reprod. 1993;8(11):1807–1812. doi:10.1093/oxfordjournals.humrep.a137938.
   PubMed Web of Science ®Google Scholar
• Farzaneh F, Afshar F. Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: an RCT. Int J Reprod Biomed. 2020;18(4):307–310.
   PubMed Web of Science ®Google Scholar
• Bider D, Hourvitz A, Tur Kaspa I, et al. Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease. J Assist Reprod Genet. 1999;16(5):233–235. doi:10.1023/a:1020307227273.
   PubMed Web of Science ®Google Scholar
• Liu S, Shi L, Wang T, et al. Effect of low-dose dexamethasone on patients with elevated early follicular phase progesterone level and pregnancy outcomes in IVF-ET treatment: a randomized controlled clinical trial. Clin Endocrinol . 2018;89(6):771–778. doi:10.1111/cen.13824.
   PubMed Web of Science ®Google Scholar
• Conforti A, Esteves SC, Pellicer A, et al. Effect of dexamethasone co-treatment during ovarian stimulation in women of different reproductive age with elevated early follicular phase progesterone level: a prospective longitudinal study. Reprod Sci. 2021;28(11):3258–3264. doi:10.1007/s43032-021-00590-7.
   PubMed Web of Science ®Google Scholar
• Boomsma CM, Kamath MS, Keay SD, et al. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev. 2022;6(6): CD005996.
   PubMedGoogle Scholar
• Ando T, Suganuma N, Furuhashi M, et al. Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. J Assist Reprod Genet. 1996;13(10):776–781. doi:10.1007/BF02066497.
   PubMed Web of Science ®Google Scholar
• Bider D, Amoday I, Tur-Kaspa I, et al. The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization–a randomized study. Hum Reprod. 1996;11(8):1606–1608. doi:10.1093/oxfordjournals.humrep.a019454.
   PubMed Web of Science ®Google Scholar
• Kemeter P, Feichtinger W. Prednisolone supplementation to clomid and/or gonadotrophin stimulation for in-vitro fertilization–a prospective randomized trial. Hum Reprod. 1986;1(7):441–444. doi:10.1093/oxfordjournals.humrep.a136451.
   PubMed Web of Science ®Google Scholar
• Kim CH, Chae HD, Kang BM, et al. The immunotherapy during in vitro fertilization and embryo transfer cycles in infertile patients with endometriosis. J Obstet Gynaecol Res. 1997;23(5):463–470. doi:10.1111/j.1447-0756.1997.tb00874.x.
   PubMedGoogle Scholar
• Mohammadi Yeganeh L, Moini A, Shiva M, et al. Methylprednisolone for prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome undergoing in-vitro fertilisation: a randomised controlled trial. J Obstet Gynaecol. 2018;38(2):241–246. doi:10.1080/01443615.2017.1346593.
   PubMedGoogle Scholar
• Fridstrom M, Carlstrom K, Sjoblom P, et al. Effect of prednisolone on serum and follicular fluid androgen concentrations in women with polycystic ovary syndrome undergoing in-vitro fertilization. Hum Reprod. 1999;14(6):1440–1444.
   PubMed Web of Science ®Google Scholar
• Rein MS, Jackson KV, Sable DB, et al. Dexamethasone during ovulation induction for in-vitro fertilization: a pilot study. Hum Reprod. 1996;11(2):253–255. doi:10.1093/HUMREP/11.2.253.
   PubMed Web of Science ®Google Scholar
• Boomsma CM, Keay SD, Macklon NS. Periimplantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev. 2007(1):CD005996.
   Google Scholar
• Smith MP, Mathur RS, Keay SD, et al. Periovulatory human oocytes, cumulus cells, and ovarian leukocytes express type 1 but not type 2 11beta-hydroxysteroid dehydrogenase RNA. Fertil Steril. 2000;73(4):825–830. doi:10.1016/s0015-0282(99)00607-x.
   PubMed Web of Science ®Google Scholar
• Fowden AL, Forhead AJ. Glucocorticoids as regulatory signals during intrauterine development. Exp Physiol. 2015;100(12):1477–1487. doi:10.1113/EP085212.
   PubMed Web of Science ®Google Scholar
• Miell JP, Taylor AM, Jones J, et al. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol. 1993;136(3):525–533. doi:10.1677/joe.0.1360525.
   PubMed Web of Science ®Google Scholar
• Willis MY, Browne AS, Session DR, et al. Controlled ovarian hyperstimulation: a review for the non-ART patient. Minerva Ginecol. 2011;63(2):119–135.
   PubMedGoogle Scholar
• Motteram C, Vollenhoven B, Hope N, et al. Live birth rates after combined adjuvant therapy in IVF-ICSI cycles: a matched case-control study. Reprod Biomed Online. 2015;30(4):340–348. doi:10.1016/j.rbmo.2014.12.004.
   PubMed Web of Science ®Google Scholar
• Vail A, Gardener E. Common statistical errors in the design and analysis of subfertility trials. Hum Reprod. 2003;18(5):1000–1004. doi:10.1093/humrep/deg133.
   PubMed Web of Science ®Google Scholar
• Tang AW, Alfirevic Z, Turner MA, et al. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod. 2013;28(7):1743–1752. doi:10.1093/humrep/det117.
   PubMed Web of Science ®Google Scholar
• Gomaa MF, Elkholy AG, El-Said MM, et al. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. Arch Gynecol Obstet. 2014;290(4):757–762. doi:10.1007/s00404-014-3262-0.
   PubMed Web of Science ®Google Scholar